BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15014986)

  • 1. Microcystic tubulopapillary carcinoma of the pancreas: a new tumor entity?
    Esposito I; Bauer A; Hoheisel JD; Kleeff J; Friess H; Bergmann F; Rieker RJ; Otto HF; Klöppel G; Penzel R
    Virchows Arch; 2004 May; 444(5):447-53. PubMed ID: 15014986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orthotopic transplantation models of pancreatic adenocarcinoma derived from cell lines and primary tumors and displaying varying metastatic activity.
    Loukopoulos P; Kanetaka K; Takamura M; Shibata T; Sakamoto M; Hirohashi S
    Pancreas; 2004 Oct; 29(3):193-203. PubMed ID: 15367885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DPC4/Smad4 expression and outcome in pancreatic ductal adenocarcinoma.
    Biankin AV; Morey AL; Lee CS; Kench JG; Biankin SA; Hook HC; Head DR; Hugh TB; Sutherland RL; Henshall SM
    J Clin Oncol; 2002 Dec; 20(23):4531-42. PubMed ID: 12454109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis.
    Moore PS; Orlandini S; Zamboni G; Capelli P; Rigaud G; Falconi M; Bassi C; Lemoine NR; Scarpa A
    Br J Cancer; 2001 Jan; 84(2):253-62. PubMed ID: 11161385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic intraepithelial neoplasia and infiltrating adenocarcinoma: analysis of progression and recurrence by DPC4 immunohistochemical labeling.
    McCarthy DM; Brat DJ; Wilentz RE; Yeo CJ; Cameron JL; Kern SE; Hruban RH
    Hum Pathol; 2001 Jun; 32(6):638-42. PubMed ID: 11431719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of DPC4/Smad4, p21wafI, and p16 in human pancreatic cancer].
    Gu LJ; Chen J; Lu ZH; Li L; Zhou WX; Luo YF
    Ai Zheng; 2002 Feb; 21(2):132-7. PubMed ID: 12479060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of beta-catenin gene mutations in pancreatic tumors.
    Gerdes B; Ramaswamy A; Simon B; Pietsch T; Bastian D; Kersting M; Moll R; Bartsch D
    Digestion; 1999; 60(6):544-8. PubMed ID: 10545724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of novel markers of pancreatic ductal adenocarcinoma in pancreatic nonductal neoplasms: additional evidence of different genetic pathways.
    Cao D; Maitra A; Saavedra JA; Klimstra DS; Adsay NV; Hruban RH
    Mod Pathol; 2005 Jun; 18(6):752-61. PubMed ID: 15696124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential roles of alterations of p53, p16, and SMAD4 expression in the progression of intraductal papillary-mucinous tumors of the pancreas.
    Sasaki S; Yamamoto H; Kaneto H; Ozeki I; Adachi Y; Takagi H; Matsumoto T; Itoh H; Nagakawa T; Miyakawa H; Muraoka S; Fujinaga A; Suga T; Satoh M; Itoh F; Endo T; Imai K
    Oncol Rep; 2003; 10(1):21-5. PubMed ID: 12469138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraductal tubulopapillary neoplasm of the pancreas on fine needle aspiration: case report with differential diagnosis.
    Guan H; Gurda G; Lennon AM; Hruban RH; Erozan YS
    Diagn Cytopathol; 2014 Feb; 42(2):156-60. PubMed ID: 22807417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression.
    Wilentz RE; Iacobuzio-Donahue CA; Argani P; McCarthy DM; Parsons JL; Yeo CJ; Kern SE; Hruban RH
    Cancer Res; 2000 Apr; 60(7):2002-6. PubMed ID: 10766191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent beta-catenin mutation and cytoplasmic/nuclear accumulation in pancreatic solid-pseudopapillary neoplasm.
    Tanaka Y; Kato K; Notohara K; Hojo H; Ijiri R; Miyake T; Nagahara N; Sasaki F; Kitagawa N; Nakatani Y; Kobayashi Y
    Cancer Res; 2001 Dec; 61(23):8401-4. PubMed ID: 11731417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal adenocarcinomas.
    Iacobuzio-Donahue CA; Klimstra DS; Adsay NV; Wilentz RE; Argani P; Sohn TA; Yeo CJ; Cameron JL; Kern SE; Hruban RH
    Am J Pathol; 2000 Sep; 157(3):755-61. PubMed ID: 10980115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixed ductal-endocrine carcinomas of the pancreas and ductal adenocarcinomas with scattered endocrine cells: characterization of the endocrine cells.
    Ohike N; Jürgensen A; Pipeleers-Marichal M; Klöppel G
    Virchows Arch; 2003 Mar; 442(3):258-65. PubMed ID: 12647216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas : a new marker of DPC4 inactivation.
    Wilentz RE; Su GH; Dai JL; Sparks AB; Argani P; Sohn TA; Yeo CJ; Kern SE; Hruban RH
    Am J Pathol; 2000 Jan; 156(1):37-43. PubMed ID: 10623651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic carcinoma in carriers of a specific 19 base pair deletion of CDKN2A/p16 (p16-leiden).
    de vos tot Nederveen Cappel WH; Offerhaus GJ; van Puijenbroek M; Caspers E; Gruis NA; De Snoo FA; Lamers CB; Griffioen G; Bergman W; Vasen HF; Morreau H
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3598-605. PubMed ID: 14506146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of microdissected tumors and preneoplastic intraductal lesions in pancreatic carcinoma.
    Heinmöller E; Dietmaier W; Zirngibl H; Heinmöller P; Scaringe W; Jauch KW; Hofstädter F; Rüschoff J
    Am J Pathol; 2000 Jul; 157(1):83-92. PubMed ID: 10880379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma.
    Tascilar M; Skinner HG; Rosty C; Sohn T; Wilentz RE; Offerhaus GJ; Adsay V; Abrams RA; Cameron JL; Kern SE; Yeo CJ; Hruban RH; Goggins M
    Clin Cancer Res; 2001 Dec; 7(12):4115-21. PubMed ID: 11751510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of DPC4 expression and its correlation with clinicopathological parameters in pancreatic carcinoma.
    Hua Z; Zhang YC; Hu XM; Jia ZG
    World J Gastroenterol; 2003 Dec; 9(12):2764-7. PubMed ID: 14669329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancer.
    Oshima M; Okano K; Muraki S; Haba R; Maeba T; Suzuki Y; Yachida S
    Ann Surg; 2013 Aug; 258(2):336-46. PubMed ID: 23470568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.